Monthly Archives: November 2024

//November

DEADLINE EXTENDED: Help inform review of sector costs

The deadline to register interest in participating in an important fiscal review of the community pharmacy sector has been extended to Monday 18th November. With pharmacies across the country struggling to cope under intolerable financial pressures, NHS England’s independent economic review offers an opportunity to demonstrate how much it actually costs to run a pharmacy [...]

The post DEADLINE EXTENDED: Help inform review of sector costs appeared first on Community Pharmacy England.

By |November 12th, 2024|Lexpos News|Comments Off on DEADLINE EXTENDED: Help inform review of sector costs

MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd)

MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd) Drug alert number: EL (24)A/54 Date issued: 12 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Omeprazole 40mg Powder for solution for infusion. Company name: Viatris [...]

The post MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd) appeared first on Community Pharmacy England.

By |November 12th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd)

Medicine Supply Notification: Sodium fusidate (Fucidin® ) 250mg tablets and fusidic acid (Fucidin® ) 250mg/5ml oral suspension

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sodium fusidate (Fucidin®) 250mg tablets and fusidic acid (Fucidin®) 250mg/5ml oral suspension MSN/2024/107 Tier 2 medium impact Date of issue: 7th October 2024 Sodium fusidate (Fucidin®) 250mg tablets will be discontinued from mid-January 2025. Fusidic acid (Fucidin®) 250mg/5ml oral suspension will [...]

The post Medicine Supply Notification: Sodium fusidate (Fucidin® ) 250mg tablets and fusidic acid (Fucidin® ) 250mg/5ml oral suspension appeared first on Community Pharmacy England.

By |November 12th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Sodium fusidate (Fucidin® ) 250mg tablets and fusidic acid (Fucidin® ) 250mg/5ml oral suspension

One Year on from Vision: LPCs and wider stakeholders consider the outlook for pharmacy

LPCs and Community Pharmacy England met with a range of advocates and patient groups last week to reflect on the outlook for the sector a year on from the publication of the Vision for Community Pharmacy. The Annual Conference of LPCs and Community Pharmacy England held last Thursday focussed on crucial considerations for the coming year, [...]

The post One Year on from Vision: LPCs and wider stakeholders consider the outlook for pharmacy appeared first on Community Pharmacy England.

By |November 11th, 2024|Lexpos News|Comments Off on One Year on from Vision: LPCs and wider stakeholders consider the outlook for pharmacy

NHS England Pharmacy First campaign to re-start on Monday

NHS England will be relaunching their Pharmacy First public-facing campaign on Monday 11th October 2024. Minor revisions have been made to the original campaign materials used earlier this year, including additional information on the age criteria for the clinical pathways. Ahead of the official launch, the campaign materials are available on the Department of Health [...]

The post NHS England Pharmacy First campaign to re-start on Monday appeared first on Community Pharmacy England.

By |November 8th, 2024|Lexpos News|Comments Off on NHS England Pharmacy First campaign to re-start on Monday